Tagrisso (osimertinib)

pCPA File Number: 21016
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-Squamous Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CDA-AMC Project Number:
PC0076-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: